To launch rapid and affordable Non-Invasive Prenatal DNA Testing (NIPT) in India
LifeCodexx, provider of non-invasive prenatal DNA testing in Europe has partnered with LifeCell – a mother and baby preventive healthcare provider, to bring PrenaTesT qNIPT testing in the Indian market. LifeCell will be able to perform the licensed qNIPT PrenaTest at LifeCell’s laboratories in Chennai.
The qNIPT technology that detects the presence of fetal trisomy 21 (Down Syndrome) from maternal blood, received CE marking (European Conformity) in December 2016 last year. This certification was obtained after a successful blinded clinical validation of around 1000 samples, demonstrating a 100 per cent credibility of test results obtained from PrenaTest. The novel qNIPT technology clearly demonstrates a significant cost-efficiency and rapid turnaround time compared to other NIPT techniques as it doesn’t rely on costly and lengthy sequencing methodology.
Prenatest will be serviced under LifeCell flagship brand BabyShield – the division specialised in mother and baby diagnostic services.
- Advertisement -
Comments are closed.